Comfortable leader
17 companies value 656 bn revenue 1.4 tn margin 1.6% free cash flow 56 bn avg. score 4.2
UNH holds 55.6% of the group's value, 3.9x the runner-up
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UNH | UnitedHealth Group United States · score 6.6 | 56% | 365 bn | 450 bn | 3.1% | 24 bn | 6.5% | 2.2% | UnitedHealthcare health plans and Optum services · World's largest health insurer; Optum is the largest employer of physicians in the US | |
| 2 | ELV | Elevance Health United States · score 5.8 | 14% | 93 bn | 201 bn | 2.5% | 6.3 bn | 6.7% | 1.6% | Anthem and Blue Cross Blue Shield health plans · 2nd largest US health insurer (Blue Cross brand in 14 states) | |
| 3 | CI | The Cigna Group United States · score 7.1 | 12% | 79 bn | 282 bn | 2.3% | 10 bn | 13.0% | 2.1% | Health plans and pharmacy benefit management · Leader in pharmacy benefit management (Evernorth) | |
| 4 | HUM | Humana United States · score 4.8 | 8% | 50 bn | 146 bn | 0.9% | 1.9 bn | 3.9% | 0.9% | Medicare Advantage health plans · Medicare Advantage specialist, the fastest-growing segment | |
| 5 | CNC | Centene United States · score 4.5 | 5% | 34 bn | 203 bn | -2.5% | 8.9 bn | 26.4% | — | Medicaid, Medicare and marketplace health plans · Largest US operator of government health plans (Medicaid) | |
| 6 | MOH | Molina Healthcare United States · score 1.9 | 2% | 11 bn | 45 bn | 0.0% | 0.3 bn | 2.5% | — | Medicaid and Medicare health plans · Specialist in government health plans for low-income people | |
| 7 | OSCR | Oscar Health, Inc. United States · score 7.7 | 2% | 10 bn | 15 bn | 3.6% | 4.4 bn | 43.6% | — | Health insurer built on its own technology platform · New York — revenue of $15.3bn | |
| 8 | PRVA | Privia Health Group, Inc. United States · score 5.5 | 0% | 2.9 bn | 2.4 bn | 1.2% | 0.1 bn | 4.6% | 0.1% | Technology platform that enables medical practices · Virginia — revenue of $2.4bn | |
| 9 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE United States · score 2.6 | 0% | 2.4 bn | 2.5 bn | -0.7% | 0.1 bn | 3.1% | — | Medicare Advantage health plan with its own technology · New Jersey — revenue of $2.5bn | |
| 10 | PGNY | Progyny, Inc. United States · score 6.7 | 0% | 2.1 bn | 1.3 bn | 6.0% | 0.2 bn | 8.4% | — | Fertility and women's health benefits for employers · New York — revenue of $1.3bn | |
| 11 | ASTH | Astrana Health, Inc. United States · score 4.4 | 0% | 1.8 bn | 3.8 bn | 1.1% | 0.1 bn | 5.2% | 0.1% | Physician-centric healthcare, with technology and risk-taking · California — revenue of $3.8bn | |
| 12 | ALHC | Alignment Healthcare, Inc. United States · score 5.5 | 0% | 1.7 bn | 4.6 bn | 0.9% | 0.2 bn | 10.2% | — | Medicare Advantage health plan · California — revenue of $4.6bn | |
| 13 | AGL | agilon health United States · score 0.0 | 0% | 1.5 bn | 5.9 bn | -3.9% | -0.1 bn | -5.7% | — | Value-based care management for primary care doctors · Organizes primary care practices into Medicare risk contracts | |
| 14 | INNV | InnovAge Holding Corp. United States · score 3.4 | 0% | 1.2 bn | 1.0 bn | -0.3% | 0.1 bn | 4.2% | — | Comprehensive capitated care for high-cost seniors · Colorado — revenue of $990m | |
| 15 | EVH | Evolent Health, Inc. United States · score 3.1 | 0% | 0.5 bn | 2.1 bn | -24.1% | 0.1 bn | 10.7% | — | Value-based care management for health plans · Virginia — revenue of $2.1bn | |
| 16 | PIII | P3 Health Partners Inc. United States · score 0.0 | 0% | 0.0 bn | 1.5 bn | -6.6% | -0.1 bn | -471.6% | — | Physician-led population health management · Illinois — revenue of $1.5bn | |
| 17 | EUDA | EUDA Health Holdings Ltd Singapore · score 1.0 | — | — | 0.0 bn | -32.7% | 0.0 bn | — | — | Affordable personalized healthcare · Singapore — revenue of $7m |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
- Molecular testing and advanced diagnostics 42 companies
and 22 industries more
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.